Rapid Single B Cell Screening for Antibody Discovery using Cyto-Mine®
Identify and isolate rare antigen-specific B cells from large heterogeneous populations in just two days
Global research efforts to identify and develop new therapeutics have stressed the need for speed and efficiency in the antibody discovery and development process. The discovery of therapeutic antibodies relies on the deep interrogation of whole B cell repertoires or hybridoma populations. Yet, screening efforts are time-consuming and costly using traditional methods.
Read our new application note for a robust and rapid single B cell screening method to identify antibodies of desired antigenic specificity without the laborious need for traditional hybridoma screening. Using this method, researchers can identify antibody-secreting cells and isolate rare cells secreting antigen-specific antibodies in just two days, significantly accelerating the time to market for therapeutics.
Download the application note:
Sphere Bio Ltd will process your personal data in strict accordance with our privacy policy which can be found here. This will include sending you updates about Sphere Bio Ltd, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send.
